10-Q Filing

BIOMERICA INC CIK: 73290 Q3 2015

Filing Information

Form Type	10-Q
Accession Number	`0001513162-15-000200`
Period End Date	20150228
Filing Date	20150414
Fiscal Year	2015
Fiscal Period	Q3
XBRL Instance	bmra-20150228.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 68 Income Statement 80 Cash Flow Statement 62 Comprehensive Income 2

Balance Sheet 68 line items

Line Item	Tag	Value	Unit	Period
Allowance for doubtful accounts (in Dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	$30.00K	USD	Point-in-time
Allowance for doubtful accounts (in Dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	$17.01K	USD	Point-in-time
Accumulated Depreciation and Amortization (in Dollars)	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$1.28M	USD	Point-in-time
Accumulated Depreciation and Amortization (in Dollars)	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$1.16M	USD	Point-in-time
Preferred stock, No Par Value (in Dollars per share)	`PreferredStockNoParValue`	-	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.17M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.47M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.67M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.51M	USD	Point-in-time
Preferred stock, No Par Value (in Dollars per share)	`PreferredStockNoParValue`	-	USD	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $17,007 and $30,000 as of February 28, 2015 and May 31, 2014,respectively	`AccountsReceivableNetCurrent`	$1.45M	USD	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $17,007 and $30,000 as of February 28, 2015 and May 31, 2014,respectively	`AccountsReceivableNetCurrent`	$931.39K	USD	Point-in-time
Preferred stock, Shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, Shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Inventories, net	`InventoryNet`	$1.77M	USD	Point-in-time
Inventories, net	`InventoryNet`	$2.11M	USD	Point-in-time
Preferred stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$103.57K	USD	Point-in-time
Preferred stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$130.09K	USD	Point-in-time
Preferred stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Deferred tax assets, current portion	`DeferredTaxAssetsNetCurrent`	$87.00K	USD	Point-in-time
Common stock, Par Value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.08	USD	Point-in-time
Common stock, Par Value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.08	USD	Point-in-time
Deferred tax assets, current portion	`DeferredTaxAssetsNetCurrent`	$87.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$4.43M	USD	Point-in-time
Common stock, Shares Authorized	`CommonStockSharesAuthorized`	25.00M	shares	Point-in-time
Common stock, Shares Authorized	`CommonStockSharesAuthorized`	25.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$4.91M	USD	Point-in-time
Property and Equipment, net of accumulated depreciation and amortization of $1,282,017 and $1,160,934 as of February 28, 2015 and May 31, 2014, respectively .	`PropertyPlantAndEquipmentNet`	$485.42K	USD	Point-in-time
Common stock, Shares Issued	`CommonStockSharesIssued`	7.55M	shares	Point-in-time
Common stock, Shares Issued	`CommonStockSharesIssued`	7.54M	shares	Point-in-time
Property and Equipment, net of accumulated depreciation and amortization of $1,282,017 and $1,160,934 as of February 28, 2015 and May 31, 2014, respectively .	`PropertyPlantAndEquipmentNet`	$614.34K	USD	Point-in-time
Common stock, Shares Outstanding	`CommonStockSharesOutstanding`	7.55M	shares	Point-in-time
Deferred Tax Assets, net of current portion	`DeferredTaxAssetsNetNoncurrent`	$359.00K	USD	Point-in-time
Common stock, Shares Outstanding	`CommonStockSharesOutstanding`	7.54M	shares	Point-in-time
Deferred Tax Assets, net of current portion	`DeferredTaxAssetsNetNoncurrent`	$359.00K	USD	Point-in-time
Investments	`Investments`	$165.32K	USD	Point-in-time
Investments	`Investments`	$165.32K	USD	Point-in-time
Intangible Assets, net	`IntangibleAssetsNetExcludingGoodwill`	$382.18K	USD	Point-in-time
Intangible Assets, net	`IntangibleAssetsNetExcludingGoodwill`	$339.98K	USD	Point-in-time
Other Assets	`OtherAssetsNoncurrent`	$36.30K	USD	Point-in-time
Other Assets	`OtherAssetsNoncurrent`	$51.09K	USD	Point-in-time
Total Assets	`Assets`	$6.47M	USD	Point-in-time
Total Assets	`Assets`	$5.83M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$441.68K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$352.94K	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$114.16K	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$130.43K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$555.84K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$483.37K	USD	Point-in-time
Commitments and Contingencies (Note 5)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 5)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, no par value authorized 5,000,000 shares, none issued and none outstanding at February 28, 2015 and May 31, 2014	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, no par value authorized 5,000,000 shares, none issued and none outstanding at February 28, 2015 and May 31, 2014	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.08 par value authorized 25,000,000 shares, issued and outstanding 7,554,714 and 7,543,714 at February 28, 2015 and May 31, 2014, respectively	`CommonStockValue`	$604.38K	USD	Point-in-time
Common stock, $0.08 par value authorized 25,000,000 shares, issued and outstanding 7,554,714 and 7,543,714 at February 28, 2015 and May 31, 2014, respectively	`CommonStockValue`	$603.50K	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapital`	$18.31M	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapital`	$18.32M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-12.14K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-10.15K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-12.99M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-13.56M	USD	Point-in-time
Total Shareholders' Equity	`StockholdersEquity`	$5.91M	USD	Point-in-time
Total Shareholders' Equity	`StockholdersEquity`	$5.35M	USD	Point-in-time
Total Liabilities and Shareholders' Equity	`LiabilitiesAndStockholdersEquity`	$6.47M	USD	Point-in-time
Total Liabilities and Shareholders' Equity	`LiabilitiesAndStockholdersEquity`	$5.83M	USD	Point-in-time

Income Statement 80 line items

Line Item	Tag	Value	Unit	Period
Net sales	`SalesRevenueNet`	$1.49M	USD	1 Quarter
Net sales	`SalesRevenueNet`	$3.44M	USD	3 Qtrs
Net sales	`SalesRevenueNet`	$1.30M	USD	1 Quarter
Net sales	`SalesRevenueNet`	$3.47M	USD	3 Qtrs
Cost of sales	`CostOfRevenue`	$2.35M	USD	3 Qtrs
Cost of sales	`CostOfRevenue`	$914.16K	USD	1 Quarter
Cost of sales	`CostOfRevenue`	$2.39M	USD	3 Qtrs
Cost of sales	`CostOfRevenue`	$840.57K	USD	1 Quarter
Gross profit	`GrossProfit`	$458.83K	USD	1 Quarter
Gross profit	`GrossProfit`	$1.08M	USD	3 Qtrs
Gross profit	`GrossProfit`	$578.56K	USD	1 Quarter
Gross profit	`GrossProfit`	$1.09M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$1.11M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$1.12M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$409.74K	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$405.77K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$562.42K	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$140.18K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$368.22K	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$184.63K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.48M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$594.37K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$1.69M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$545.95K	USD	1 Quarter
(Loss) income from operations	`OperatingIncomeLoss`	$-135.54K	USD	1 Quarter
(Loss) income from operations	`OperatingIncomeLoss`	$-388.60K	USD	3 Qtrs
(Loss) income from operations	`OperatingIncomeLoss`	$-609.51K	USD	3 Qtrs
(Loss) income from operations	`OperatingIncomeLoss`	$32.62K	USD	1 Quarter
Dividend and interest income	`InvestmentIncomeInterestAndDividend`	$13.68K	USD	3 Qtrs
Dividend and interest income	`InvestmentIncomeInterestAndDividend`	$1.72K	USD	1 Quarter
Dividend and interest income	`InvestmentIncomeInterestAndDividend`	$3.48K	USD	1 Quarter
Dividend and interest income	`InvestmentIncomeInterestAndDividend`	$18.42K	USD	3 Qtrs
Interest expense	`InterestExpense`	$20.00	USD	1 Quarter
Interest expense	`InterestExpense`	$17.00	USD	3 Qtrs
Interest expense	`InterestExpense`	-	USD	1 Quarter
Interest expense	`InterestExpense`	$80.00	USD	3 Qtrs
Total other income	`NonoperatingIncomeExpense`	$18.40K	USD	3 Qtrs
Total other income	`NonoperatingIncomeExpense`	$1.72K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$13.60K	USD	3 Qtrs
Total other income	`NonoperatingIncomeExpense`	$3.46K	USD	1 Quarter
(Loss) income before income tax	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-133.81K	USD	1 Quarter
(Loss) income before income tax	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-591.10K	USD	3 Qtrs
(Loss) income before income tax	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-375.00K	USD	3 Qtrs
(Loss) income before income tax	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$36.08K	USD	1 Quarter
Credit (provision) for income taxes	`IncomeTaxExpenseBenefit`	$9.54K	USD	1 Quarter
Credit (provision) for income taxes	`IncomeTaxExpenseBenefit`	$9.54K	USD	3 Qtrs
Credit (provision) for income taxes	`IncomeTaxExpenseBenefit`	$-16.62K	USD	3 Qtrs
Credit (provision) for income taxes	`IncomeTaxExpenseBenefit`	$-16.62K	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$26.54K	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-117.19K	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-384.53K	USD	3 Qtrs
Net (loss) income	`NetIncomeLoss`	$-574.48K	USD	3 Qtrs
Basic net (loss) income per common share (in Dollars per share)	`EarningsPerShareBasic`	-	USD	1 Quarter
Basic net (loss) income per common share (in Dollars per share)	`EarningsPerShareBasic`	$-0.08	USD	3 Qtrs
Basic net (loss) income per common share (in Dollars per share)	`EarningsPerShareBasic`	$-0.05	USD	3 Qtrs
Basic net (loss) income per common share (in Dollars per share)	`EarningsPerShareBasic`	$-0.02	USD	1 Quarter
Diluted net (loss) income per common share (in Dollars per share)	`EarningsPerShareDiluted`	$-0.05	USD	3 Qtrs
Diluted net (loss) income per common share (in Dollars per share)	`EarningsPerShareDiluted`	$-0.02	USD	1 Quarter
Diluted net (loss) income per common share (in Dollars per share)	`EarningsPerShareDiluted`	$-0.08	USD	3 Qtrs
Diluted net (loss) income per common share (in Dollars per share)	`EarningsPerShareDiluted`	-	USD	1 Quarter
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	7.31M	shares	3 Qtrs
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	7.55M	shares	3 Qtrs
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	7.55M	shares	1 Quarter
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	7.38M	shares	1 Quarter
Diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	7.31M	shares	3 Qtrs
Diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	7.55M	shares	3 Qtrs
Diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	7.73M	shares	1 Quarter
Diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	7.55M	shares	1 Quarter
Net (loss) income	`NetIncomeLoss`	$26.54K	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-117.19K	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-384.53K	USD	3 Qtrs
Net (loss) income	`NetIncomeLoss`	$-574.48K	USD	3 Qtrs
Foreign currency translation	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-1.99K	USD	3 Qtrs
Foreign currency translation	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-308.00	USD	1 Quarter
Foreign currency translation	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-1.11K	USD	1 Quarter
Foreign currency translation	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-1.11K	USD	3 Qtrs
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTax`	$-576.47K	USD	3 Qtrs
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTax`	$25.43K	USD	1 Quarter
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTax`	$-385.65K	USD	3 Qtrs
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTax`	$-117.50K	USD	1 Quarter

Cash Flow Statement 62 line items

Line Item	Tag	Value	Unit	Period
Net (loss)	`NetIncomeLoss`	$26.54K	USD	1 Quarter
Net (loss)	`NetIncomeLoss`	$-117.19K	USD	1 Quarter
Net (loss)	`NetIncomeLoss`	$-384.53K	USD	3 Qtrs
Net (loss)	`NetIncomeLoss`	$-574.48K	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$148.62K	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$192.67K	USD	3 Qtrs
Stock option expense	`StockOptionPlanExpense`	$6.06K	USD	3 Qtrs
Stock option expense	`StockOptionPlanExpense`	$11.00K	USD	3 Qtrs
Change in provision for losses on accounts receivable	`ProvisionForDoubtfulAccounts`	$-12.99K	USD	3 Qtrs
Change in provision for losses on accounts receivable	`ProvisionForDoubtfulAccounts`	$4.67K	USD	3 Qtrs
Gain on disposal of fixed asset	`GainLossOnSaleOfPropertyPlantEquipment`	$665.00	USD	3 Qtrs
Gain on disposal of fixed asset	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	3 Qtrs
Inventory reserve	`InventoryLIFOReservePeriodCharge`	$-6.71K	USD	3 Qtrs
Inventory reserve	`InventoryLIFOReservePeriodCharge`	$7.33K	USD	3 Qtrs
Decrease in deferred rent liability	`IncreaseDecreaseInDeferredRentLiability`	$-10.11K	USD	3 Qtrs
Decrease in deferred rent liability	`IncreaseDecreaseInDeferredRentLiability`	$-14.83K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$304.78K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-529.30K	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$360.41K	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$352.35K	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-55.67K	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$26.52K	USD	3 Qtrs
Accounts payable and other accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$81.32K	USD	3 Qtrs
Accounts payable and other accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-73.90K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	-	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$14.79K	USD	3 Qtrs
Accrued compensation	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$16.26K	USD	3 Qtrs
Accrued compensation	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-87.65K	USD	3 Qtrs
Net cash (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-318.91K	USD	3 Qtrs
Net cash (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-852.90K	USD	3 Qtrs
Proceeds from sale of equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	3 Qtrs
Proceeds from sale of equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$1.90K	USD	3 Qtrs
Increases in intangibles	`PaymentsToAcquireIntangibleAssets`	-	USD	3 Qtrs
Increases in intangibles	`PaymentsToAcquireIntangibleAssets`	$14.13K	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$117.36K	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$8.66K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-20.89K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-117.36K	USD	3 Qtrs
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$150.00K	USD	3 Qtrs
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	3 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$17.27K	USD	3 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$4.36K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$167.28K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$4.36K	USD	3 Qtrs
Effect of exchange rate changes in cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-1.11K	USD	3 Qtrs
Effect of exchange rate changes in cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-1.99K	USD	3 Qtrs
Net decrease in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-337.44K	USD	3 Qtrs
Net decrease in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-804.11K	USD	3 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.17M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.47M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.67M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.51M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.17M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.47M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.67M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.51M	USD	Point-in-time
Interest	`InterestPaid`	$80.00	USD	3 Qtrs
Interest	`InterestPaid`	$17.00	USD	3 Qtrs
Income taxes	`IncomeTaxesPaid`	$9.54K	USD	3 Qtrs
Income taxes	`IncomeTaxesPaid`	$800.00	USD	3 Qtrs
Payment of international regulatory approval fees in Exchange for $100,000 due on agreement to purchase Biomerica restricted stock	`PaymentOfInternationalRegulatoryApprovalFees`	$100.00K	USD	3 Qtrs
Payment of international regulatory approval fees in Exchange for $100,000 due on agreement to purchase Biomerica restricted stock	`PaymentOfInternationalRegulatoryApprovalFees`	-	USD	3 Qtrs

Comprehensive Income 2 line items

Line Item	Tag	Value	Unit	Period
Amount due on agreement to purchase restricted stock	`AmountDueOnAgreementToPurchaseRestrictedStock`	-	USD	3 Qtrs
Amount due on agreement to purchase restricted stock	`AmountDueOnAgreementToPurchaseRestrictedStock`	$100.00K	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.